Phillip Paull

485 total citations
20 papers, 377 citations indexed

About

Phillip Paull is a scholar working on Pharmacology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Phillip Paull has authored 20 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Pharmacology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Phillip Paull's work include Pharmacogenetics and Drug Metabolism (4 papers), Alcohol Consumption and Health Effects (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Phillip Paull is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Alcohol Consumption and Health Effects (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Phillip Paull collaborates with scholars based in Australia, South Korea and United States. Phillip Paull's co-authors include Richard O. Day, G. David Champion, Garry G. Graham, Mark A. Evans, Malcolm McDonald, Eugene Athan, Helen Creasey, Mui Cheung, E. J. Triggs and M. Lindsay Grayson and has published in prestigious journals such as Hepatology, Neurology and Clinical Infectious Diseases.

In The Last Decade

Phillip Paull

20 papers receiving 339 citations

Peers

Phillip Paull
Anthony R. Temple United States
E. F. S. Termond Netherlands
P. Barriot France
G. Traversa Italy
Uwe Tröger Germany
Jerry W. Taylor United States
Robert M. Stote United States
R. F. Johnson United States
Sinem Ezgi Gülmez Türkiye
Burde L. Kamath United States
Anthony R. Temple United States
Phillip Paull
Citations per year, relative to Phillip Paull Phillip Paull (= 1×) peers Anthony R. Temple

Countries citing papers authored by Phillip Paull

Since Specialization
Citations

This map shows the geographic impact of Phillip Paull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Paull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Paull more than expected).

Fields of papers citing papers by Phillip Paull

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Paull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Paull. The network helps show where Phillip Paull may publish in the future.

Co-authorship network of co-authors of Phillip Paull

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Paull. A scholar is included among the top collaborators of Phillip Paull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Paull. Phillip Paull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ball, M. Bethany, et al.. (2018). Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons. Journal of Translational Medicine. 16(1). 24–24. 28 indexed citations
2.
3.
4.
Ioannides‐Demos, Lisa L., et al.. (1999). Cephalosporin clinical concentration–time profile modelling and in-vitro bactericidal effects on Escherichia coli. Journal of Antimicrobial Chemotherapy. 44(4). 471–476. 3 indexed citations
5.
Day, Richard O., et al.. (1995). The effect of tenoxicam on tolbutamide pharmacokinetics and glucose concentrations in healthy volunteers.. PubMed. 33(5). 308–10. 5 indexed citations
6.
Callaghan, Richard, Phillip Paull, Paul Desmond, & Maurice L. Mashford. (1994). Factors affecting the hepatic elimination of oxidized and of glucoronidated high clearance drugs following acute administration of carbon tetrachloride. Journal of Hepatology. 20(6). 742–749. 2 indexed citations
7.
Day, Richard O., et al.. (1994). Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteers.. British Journal of Clinical Pharmacology. 37(1). 79–81. 3 indexed citations
8.
Callaghan, Richard, et al.. (1993). Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis. Hepatology. 18(1). 54–60. 12 indexed citations
9.
Wallace, Sophie, et al.. (1990). Covert self poisoning with brodifacoum, a ‘superwarfarin’. Australian and New Zealand Journal of Medicine. 20(5). 713–715. 8 indexed citations
10.
Day, Richard O., et al.. (1987). Effect of food and various antacids on the absorption of tenoxicam.. British Journal of Clinical Pharmacology. 24(3). 323–328. 15 indexed citations
11.
Paull, Phillip, et al.. (1986). Evidence that alpha-methyl-p-tyramine is implicated in behavioural augmentation to amphetamine. General Pharmacology The Vascular System. 17(4). 453–456. 8 indexed citations
12.
Paull, Phillip, et al.. (1984). On the Measurement of Cyclosporine in Plasma. Therapeutic Drug Monitoring. 6(3). 373–373. 1 indexed citations
13.
Evans, Mark A., G. Anthony Broe, E. J. Triggs, et al.. (1981). Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient. Neurology. 31(10). 1288–1288. 53 indexed citations
14.
Champion, G. David, et al.. (1978). Clinical Pharmacology and Efficacy of Benorylate in Patients with Rheumatoid Arthritis. Australian and New Zealand Journal of Medicine. 8(1). 22–28. 3 indexed citations
15.
Howe, Graydon, G. David Champion, John Hewson, et al.. (1977). The Effects of Enteric Coating of Aspirin Tablets on Occult Gastrointestinal Blood Loss. Australian and New Zealand Journal of Medicine. 7(6). 600–604. 11 indexed citations
16.
Graham, Garry G., G. David Champion, Richard O. Day, & Phillip Paull. (1977). Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis. Clinical Pharmacology & Therapeutics. 22(4). 410–420. 84 indexed citations
17.
Day, Richard O., Phillip Paull, John E. Ray, & D. N. Wade. (1977). The measurement of histamine release from suspensions of rat peritoneal cells rich in mast cells. Inflammation Research. 7(4). 431–436. 2 indexed citations
18.
Day, Richard O., et al.. (1976). Evaluation of an Enteric Coated Aspirin Preparation. Australian and New Zealand Journal of Medicine. 6(1). 45–50. 14 indexed citations
19.
Champion, G. David, et al.. (1975). Salicylates in Rheumatoid Arthritis. Clinics in Rheumatic Diseases. 1(2). 245–265. 14 indexed citations
20.
Paull, Phillip, Richard O. Day, Garry G. Graham, & G. David Champion. (1962). SINGLE‐DOSE EVALUATION OF A NEW ENTERIC‐COATED ASPIRIN PREPARATION. The Medical Journal of Australia. 1(17). 617–619. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony R. Temple Breakdown of academic impact, for papers by E. F. S. Termond Breakdown of academic impact, for papers by P. Barriot Breakdown of academic impact, for papers by G. Traversa Breakdown of academic impact, for papers by Uwe Tröger Breakdown of academic impact, for papers by Jerry W. Taylor Breakdown of academic impact, for papers by Robert M. Stote Breakdown of academic impact, for papers by R. F. Johnson Breakdown of academic impact, for papers by Sinem Ezgi Gülmez Breakdown of academic impact, for papers by Burde L. Kamath
Rankless by CCL
2026